Industry: Pharma & Healthcare
Published Date: 2024-01-12
Pages: 97 Pages
Report ld: 2210211
Request Sample
Customized Report
The global Livestock Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Livestock Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Livestock Vaccines.
MARKET SEGMENTATION
REPORT SCOPE
The Livestock Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Livestock Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Livestock Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Livestock Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Livestock Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Livestock Vaccines Market Overview
1.1 Product Overview and Scope of Livestock Vaccines
1.2 Livestock Vaccines Segment by Type
1.2.1 Global Livestock Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Foot and Mouth Disease Vaccine
1.2.3 Pig Ring Vaccine
1.2.4 Bird Flu Vaccine
1.2.5 Porcine Blue Ear Vaccine
1.2.6 Swine Fever Vaccine
1.3 Livestock Vaccines Segment by Application
1.3.1 Global Livestock Vaccines Market Value by Application: (2024-2030)
1.3.2 Pig
1.3.3 Cattle and Sheep
1.3.4 Others
1.4 Global Livestock Vaccines Market Size Estimates and Forecasts
1.4.1 Global Livestock Vaccines Revenue 2019-2030
1.4.2 Global Livestock Vaccines Sales 2019-2030
1.4.3 Global Livestock Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Livestock Vaccines Market Competition by Manufacturers
2.1 Global Livestock Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Livestock Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Livestock Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Livestock Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Livestock Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Livestock Vaccines, Product Type & Application
2.7 Livestock Vaccines Market Competitive Situation and Trends
2.7.1 Livestock Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Livestock Vaccines Players Market Share by Revenue
2.7.3 Global Livestock Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Livestock Vaccines Retrospective Market Scenario by Region
3.1 Global Livestock Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Livestock Vaccines Global Livestock Vaccines Sales by Region: 2019-2030
3.2.1 Global Livestock Vaccines Sales by Region: 2019-2024
3.2.2 Global Livestock Vaccines Sales by Region: 2025-2030
3.3 Global Livestock Vaccines Global Livestock Vaccines Revenue by Region: 2019-2030
3.3.1 Global Livestock Vaccines Revenue by Region: 2019-2024
3.3.2 Global Livestock Vaccines Revenue by Region: 2025-2030
3.4 North America Livestock Vaccines Market Facts & Figures by Country
3.4.1 North America Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Livestock Vaccines Sales by Country (2019-2030)
3.4.3 North America Livestock Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Livestock Vaccines Market Facts & Figures by Country
3.5.1 Europe Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Livestock Vaccines Sales by Country (2019-2030)
3.5.3 Europe Livestock Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Livestock Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Livestock Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Livestock Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Livestock Vaccines Market Facts & Figures by Country
3.7.1 Latin America Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Livestock Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Livestock Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Livestock Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Livestock Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Livestock Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Livestock Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Livestock Vaccines Sales by Type (2019-2030)
4.1.1 Global Livestock Vaccines Sales by Type (2019-2024)
4.1.2 Global Livestock Vaccines Sales by Type (2025-2030)
4.1.3 Global Livestock Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Livestock Vaccines Revenue by Type (2019-2030)
4.2.1 Global Livestock Vaccines Revenue by Type (2019-2024)
4.2.2 Global Livestock Vaccines Revenue by Type (2025-2030)
4.2.3 Global Livestock Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Livestock Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Livestock Vaccines Sales by Application (2019-2030)
5.1.1 Global Livestock Vaccines Sales by Application (2019-2024)
5.1.2 Global Livestock Vaccines Sales by Application (2025-2030)
5.1.3 Global Livestock Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Livestock Vaccines Revenue by Application (2019-2030)
5.2.1 Global Livestock Vaccines Revenue by Application (2019-2024)
5.2.2 Global Livestock Vaccines Revenue by Application (2025-2030)
5.2.3 Global Livestock Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Livestock Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Livestock Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Livestock Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Ceva
6.3.1 Ceva Corporation Information
6.3.2 Ceva Description and Business Overview
6.3.3 Ceva Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ceva Livestock Vaccines Product Portfolio
6.3.5 Ceva Recent Developments/Updates
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description and Business Overview
6.4.3 Zoetis Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zoetis Livestock Vaccines Product Portfolio
6.4.5 Zoetis Recent Developments/Updates
6.5 Vaxxinova®
6.5.1 Vaxxinova® Corporation Information
6.5.2 Vaxxinova® Description and Business Overview
6.5.3 Vaxxinova® Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vaxxinova® Livestock Vaccines Product Portfolio
6.5.5 Vaxxinova® Recent Developments/Updates
6.6 Elanco
6.6.1 Elanco Corporation Information
6.6.2 Elanco Description and Business Overview
6.6.3 Elanco Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Elanco Livestock Vaccines Product Portfolio
6.6.5 Elanco Recent Developments/Updates
6.7 QYH Biotech Co., Ltd
6.6.1 QYH Biotech Co., Ltd Corporation Information
6.6.2 QYH Biotech Co., Ltd Description and Business Overview
6.6.3 QYH Biotech Co., Ltd Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 QYH Biotech Co., Ltd Livestock Vaccines Product Portfolio
6.7.5 QYH Biotech Co., Ltd Recent Developments/Updates
6.8 Pulike
6.8.1 Pulike Corporation Information
6.8.2 Pulike Description and Business Overview
6.8.3 Pulike Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pulike Livestock Vaccines Product Portfolio
6.8.5 Pulike Recent Developments/Updates
6.9 Phibro Animal Health Corporation
6.9.1 Phibro Animal Health Corporation Corporation Information
6.9.2 Phibro Animal Health Corporation Description and Business Overview
6.9.3 Phibro Animal Health Corporation Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Phibro Animal Health Corporation Livestock Vaccines Product Portfolio
6.9.5 Phibro Animal Health Corporation Recent Developments/Updates
6.10 JinYu Biotechnology
6.10.1 JinYu Biotechnology Corporation Information
6.10.2 JinYu Biotechnology Description and Business Overview
6.10.3 JinYu Biotechnology Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 JinYu Biotechnology Livestock Vaccines Product Portfolio
6.10.5 JinYu Biotechnology Recent Developments/Updates
6.11 Harbin Pharmaceutical Group
6.11.1 Harbin Pharmaceutical Group Corporation Information
6.11.2 Harbin Pharmaceutical Group Livestock Vaccines Description and Business Overview
6.11.3 Harbin Pharmaceutical Group Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Harbin Pharmaceutical Group Livestock Vaccines Product Portfolio
6.11.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.12 MEVAC
6.12.1 MEVAC Corporation Information
6.12.2 MEVAC Livestock Vaccines Description and Business Overview
6.12.3 MEVAC Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 MEVAC Livestock Vaccines Product Portfolio
6.12.5 MEVAC Recent Developments/Updates
6.13 Venky's
6.13.1 Venky's Corporation Information
6.13.2 Venky's Livestock Vaccines Description and Business Overview
6.13.3 Venky's Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Venky's Livestock Vaccines Product Portfolio
6.13.5 Venky's Recent Developments/Updates
6.14 Japfa Comfeed Indonesia
6.14.1 Japfa Comfeed Indonesia Corporation Information
6.14.2 Japfa Comfeed Indonesia Livestock Vaccines Description and Business Overview
6.14.3 Japfa Comfeed Indonesia Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Japfa Comfeed Indonesia Livestock Vaccines Product Portfolio
6.14.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.15 Nisseiken
6.15.1 Nisseiken Corporation Information
6.15.2 Nisseiken Livestock Vaccines Description and Business Overview
6.15.3 Nisseiken Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Nisseiken Livestock Vaccines Product Portfolio
6.15.5 Nisseiken Recent Developments/Updates
6.16 Hile
6.16.1 Hile Corporation Information
6.16.2 Hile Livestock Vaccines Description and Business Overview
6.16.3 Hile Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Hile Livestock Vaccines Product Portfolio
6.16.5 Hile Recent Developments/Updates
6.17 Hester Biosciences
6.17.1 Hester Biosciences Corporation Information
6.17.2 Hester Biosciences Livestock Vaccines Description and Business Overview
6.17.3 Hester Biosciences Livestock Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Hester Biosciences Livestock Vaccines Product Portfolio
6.17.5 Hester Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Livestock Vaccines Industry Chain Analysis
7.2 Livestock Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Livestock Vaccines Production Mode & Process
7.4 Livestock Vaccines Sales and Marketing
7.4.1 Livestock Vaccines Sales Channels
7.4.2 Livestock Vaccines Distributors
7.5 Livestock Vaccines Customers
8 Livestock Vaccines Market Dynamics
8.1 Livestock Vaccines Industry Trends
8.2 Livestock Vaccines Market Drivers
8.3 Livestock Vaccines Market Challenges
8.4 Livestock Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Livestock Vaccines was valued at US$ 4857 million in the year 2024 and is projected to reach a revised size of US$ 6380 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Published Date: 2025-01-01
Pages: 101
USD 2900.00
(Single User License)
Livestock vaccines are substances used to stimulate an immune response in animals, providing them with immunity against specific diseases. Vaccination is a critical component of livestock management as it helps prevent the spread of infectious diseases, reduces economic losses, and ensures the overall health and well-being of the animal population. Various vaccines are developed and administered to livestock, including cattle, sheep, goats, pigs, poultry, and other farm animals.
Published Date: 2024-04-12
Pages: 116
USD 4900.00
(Single User License)
Livestock vaccines are substances used to stimulate an immune response in animals, providing them with immunity against specific diseases. Vaccination is a critical component of livestock management as it helps prevent the spread of infectious diseases, reduces economic losses, and ensures the overall health and well-being of the animal population. Various vaccines are developed and administered to livestock, including cattle, sheep, goats, pigs, poultry, and other farm animals.
Published Date: 2024-01-08
Pages: 132
USD 3950.00
(Single User License)
The global market for Livestock Vaccines was valued at US$ 4857 million in the year 2024 and is projected to reach a revised size of US$ 6380 million by 2031, growing at a CAGR of 4.0% during the forecast period.
Published: 2025-01-01
Pages: 101
Livestock vaccines are substances used to stimulate an immune response in animals, providing them with immunity against specific diseases. Vaccination is a critical component of livestock management as it helps prevent the spread of infectious diseases, reduces economic losses, and ensures the overall health and well-being of the animal population. Various vaccines are developed and administered to livestock, including cattle, sheep, goats, pigs, poultry, and other farm animals.
Published: 2024-04-12
Pages: 116
Livestock vaccines are substances used to stimulate an immune response in animals, providing them with immunity against specific diseases. Vaccination is a critical component of livestock management as it helps prevent the spread of infectious diseases, reduces economic losses, and ensures the overall health and well-being of the animal population. Various vaccines are developed and administered to livestock, including cattle, sheep, goats, pigs, poultry, and other farm animals.
Published: 2024-01-08
Pages: 132
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now